DMCC SPECIALITY CHEMICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on May 05, 2025.
DMCC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 3.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
DMCC Speciality Chemicals announced audited standalone and consolidated results for Q4 and FY ended March 31, 2025, along with a clean (unmodified) audit opinion. Standalone net sales for FY25 rose to Rs. 43,123.19 lakhs, up roughly 31.5% from Rs. 32,791.99 lakhs in FY24, while net profit jumped about 86% to Rs. 2,153.97 lakhs (from Rs. 1,157.08 lakhs). EPS for the year came in at Rs. 8.64 vs Rs. 4.64 previously. The Board recommended a final dividend of Rs. 2.50 per share (25% on face value of Rs. 10), subject to shareholder approval. It also appointed Shri Satish Kumar Jain as Secretarial Auditor for five years (FY26–FY30), re-appointed Shri S. S. Dongare as Cost Auditor for FY26, and scheduled the 104th AGM for September 10, 2025. Operating cash flow stayed healthy at around Rs. 3,800 lakhs, and long-term borrowings were reduced year-on-year.
Strong top-line and bottom-line growth along with a healthy dividend should be viewed positively by shareholders. The clean audit opinion, deleveraging, and continued positive operating cash flow support confidence in the company's earnings quality, though investors should watch for margin trends given rising raw material costs.